Citi downgraded Moderna after its large run-up, citing valuation concerns, coinciding with the sharp decline.
News event dated 2026-09-30, MarketWatch Top Stories: Citi downgrades Moderna after 600%-plus gains, citing unjustified valuations
Moved 5.4%, at or above the 3% floor for this strip